https://www.myelom.org/forum?view=topic&defaultmenu=447&catid=3&id=5624&layout=default&start=12
Erfahrungen mit Isatuximab, Carfilzomib, Dexa - analog Ikema Studie? - AMM-Online - Ergebnisse von...
Oct 18, 2023 - Hallo, bei meinem Mann ist das Rezidiv wohl da, und man hat schon mal ‚ Isatuximab, Carfilzomib, Dexa - lt. Ikema Studie‘ in den Raum gestellt. Da wollte ich...
erfahrungenmitisatuximabcarfilzomibdexa
https://www.fundacionpethema.es/publicaciones-targeting-cd38-isatuximab-and-novel-cd38cd3cd28-trispecific-t-cell-engager-older-1
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older...
t cell engagertargetingisatuximabnoveltrispecific
https://www.regionalcancercare.org/trials/a-non-interventional-multinational-observational-study-with-isatuximab-in-patients-with-relapsed-and-or-refractory-multiple-myeloma-rrmm-3/
A non-interventional, multinational, observational study with isatuximab in patients with relapsed...
observational studynoninterventionalmultinationalisatuximab
https://ematoinfo.it/news/mieloma-multiplo-nuovi-traguardi-per-la-tripletta-con-isatuximab/
Mieloma multiplo, nuovi traguardi per la tripletta con isatuximab - Ematoinfo
Apr 7, 2022 - L’AIFA ha pubblicato la determina di rimborsabilità per l’utilizzo dell’anticorpo monoclonale isatuximab, in combinazione con Kd, come trattamento del mieloma...
mielomamultiplonuovitraguardiper
https://www.horizonscangeneesmiddelen.nl/geneesmiddelen/isatuximab?versie=versie-7
Isatuximab | Hematology | Medicines | Horizonscan geneesmiddelen
In Combination With Bortezomib, Lenalidomide and Dexamethasone (Isa VRd) in Patients With Newly Diagnosed Multiple Myeloma (NDMM) Not Eligible for Transplant.
isatuximabhematologymedicinesgeneesmiddelen